Tc Biopharm holdings Plc (TCBP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TCBP Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Tc Biopharm holdings Plc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2024)
0 0 (Mar 31 2024) (Dec 31 2023)
Assets
Cash & cash equivalent1.50
Cash & Short-term Investments1.00
Other Current Assets0.65
Prepaid Expense And Other Assets Current5.49
Total Current Assets7.23
Equipment/Property/Plant Net0.95
Intangible Assets0.47
Other Assets, Noncurrent1.13
Corporation Tax Receivable-
Operating Lease Right Of Use Asset-
Total Assets10.43
Liabilities
Accounts Payable and Accrued Liabilities, Current LI4.78
Derivative Liability, Current DE0.00
Other Liabilities, Current0.33
Total Current Liabilities5.19
Long-term Debt Convertible0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent1.17
OperatingLeaseLiabilityNoncurrent-
Operating Lease Liability Current-
Total Liabilities6.66
Stockholders' Equity
Deferred Stock Value-
Common Stock Value0.26
Additional Paid In Capital Common Stock68.76
Retained Earnings / Accumulated Deficit-65.81
Other Equity0.00
Common Stockholder's Equity3.77
Total Stockholder's Equity3.80
Liabilities & Stockholder's Equity10.43
4 historic quarters locked

Sign in to unlock the full Tc Biopharm holdings Plc balance sheet history.

About Tc Biopharm holdings Plc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20240331)
  • Filed with the SEC: May 15, 2024
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-24-019840

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.